Clinical inquiries. How should we monitor men receiving testosterone replacement therapy?
Monitor hematocrit and bone mineral density (BMD) (strength of recommendation [SOR]: B, meta-analysis of non, patient-oriented outcomes). Monitoring prostate-specific antigen (PSA), performing prostate digital rectal examination, and observing symptom response to testosterone are also recommended, although direct evidence is lacking (SOR: C, consensus opinion).
University of Washington, Seattle, WA, USA.
Manuel
M
Alsina
Leilani
L
St Anna
D000728:Androgens / Q000009:adverse effects*; D016903:Drug Monitoring; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013739:Testosterone / Q000009:adverse effects*
D000728:Androgens; D013739:Testosterone